CD63 and metabolic dysfunction-associated steatotic liver disease: In this study, the lean MASLD patients exhibited higher EV CD63 and lower PLIN3-to-CD63 ratios (Table 3, Figure 6) than non-MASLD controls and obese MASLD patients.